tag:blogger.com,1999:blog-9551150.post1686811758766812005..comments2024-03-28T01:27:23.408-04:00Comments on Health Care Renewal: More Details and Concerns About the Death of a Gene-Therapy PatientRoy M. Poses MDhttp://www.blogger.com/profile/00497209843184497847noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-9551150.post-40203572471883378272007-09-02T09:47:00.000-04:002007-09-02T09:47:00.000-04:00Excellent post and I wholeheartedly agree with you...Excellent post and I wholeheartedly agree with your conclusions. However, corporate profit is not really a practical motivating factor that could perhaps pressurise a researcher into being reluctant to pull the plug on a programme. In an enviroment of corporate cutbacks, simple factors like ambition or even job security are at the back of a lot of researcher's minds these days. So having a Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-9551150.post-53362765877803746442007-08-20T13:45:00.000-04:002007-08-20T13:45:00.000-04:00This runs deeper than research. As a patient in th...This runs deeper than research. As a patient in the fast moving world of modern medicine I have been prescribed medications with no testing, and no reason, other than the doctor's know it is safe. Just ask the drug rep.<BR/><BR/>Relating to a previous post I have had the other fight with the doctor about prescribing generics. The doctor flatly stated that all generics are junk and we need to Anonymousnoreply@blogger.com